A detailed history of Massachusetts Financial Services CO transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 171,856 shares of VYGR stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
171,856
Previous 143,523 19.74%
Holding current value
$1.02 Million
Previous $1.14 Million 11.45%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.77 - $9.27 $163,481 - $262,646
28,333 Added 19.74%
171,856 $1.01 Million
Q2 2024

Aug 09, 2024

BUY
$7.42 - $10.54 $35,734 - $50,760
4,816 Added 3.47%
143,523 $1.14 Million
Q1 2024

May 14, 2024

BUY
$7.15 - $10.84 $198,634 - $301,146
27,781 Added 25.04%
138,707 $1.29 Million
Q4 2023

Feb 08, 2024

SELL
$6.28 - $8.81 $22,011 - $30,879
-3,505 Reduced 3.06%
110,926 $936,000
Q3 2023

Nov 08, 2023

BUY
$7.55 - $11.25 $863,954 - $1.29 Million
114,431 New
114,431 $886,000
Q2 2021

Aug 13, 2021

SELL
$3.94 - $5.44 $216,219 - $298,536
-54,878 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$4.61 - $9.04 $266,020 - $521,653
-57,705 Reduced 51.26%
54,878 $258,000
Q4 2020

Feb 12, 2021

SELL
$7.15 - $12.28 $8,072 - $13,864
-1,129 Reduced 0.99%
112,583 $805,000
Q3 2020

Nov 12, 2020

SELL
$10.01 - $13.75 $44,614 - $61,283
-4,457 Reduced 3.77%
113,712 $1.21 Million
Q2 2020

Aug 11, 2020

BUY
$8.05 - $14.21 $951,260 - $1.68 Million
118,169 New
118,169 $1.49 Million

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $228M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.